Opioids Drugs Market by Product, Application and Region – Global Market Size Estimation, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029
4.54%
CAGR (2023-2029)
31.17 USD Bn.
Market Size
310
Report Pages
144
Market Tables
Overview
Opioids Drugs Market was valued at USD 31.17 Bn in 2025 and is expected to reach USD 42.53 Bn by 2032, at a CAGR of 4.54% during a forecast period.
To know about the Research Methodology:-Request Free Sample Report
Opioids Drugs Market Segment Analysis
The global opioids drugs market is segmented based on product type, application, route of administration, distribution channel, and end user. Based on product type, the extended-release (ER) opioids segment dominates the market, owing to their prolonged therapeutic effect and widespread use in managing chronic pain conditions such as cancer-related pain and musculoskeletal disorders.
By route of administration, the injectable segment dominates, particularly in hospital settings where rapid pain relief is required for severe conditions, while oral formulations are widely used for long-term pain management. Based on distribution channel, retail pharmacies account for the largest share, supported by high prescription volumes and easy accessibility of opioid medications.
From an end-user perspective, hospitals lead the market, owing to the high number of surgical procedures, trauma cases, and cancer treatments requiring opioid-based pain management. Specialty clinics and homecare settings also contribute significantly, with homecare emerging as a growing segment due to increasing preference for outpatient pain management. Overall, the segmentation reflects strong demand driven by the rising burden of chronic pain and expanding healthcare infrastructure.
Opioids Drugs Market Regional Analysis
Regionally, North America dominates the global opioids drugs market, accounting for the largest share due to high prescription rates, advanced healthcare infrastructure, and a significant patient population suffering from chronic pain and cancer. The presence of major pharmaceutical companies and well-established regulatory frameworks further supports market growth in the region. Europe holds the second-largest share, driven by increasing awareness regarding pain management therapies and the availability of advanced healthcare services. Meanwhile, the Asia-Pacific region is expected to witness the fastest growth during the forecast period (2026–2032), owing to rising healthcare expenditure, increasing surgical procedures, and improving access to pain management treatments in countries such as India and China.
Recent Industry Developments (2025–2026)
| Exact Date | Company | Development | Impact |
|---|---|---|---|
| 11 March 2026 | Indivior Pharmaceuticals, Inc. | The company published a new real-world study in Frontiers in Public Health regarding its monthly injectable opioid treatment, SUBLOCADE (extended-release buprenorphine). | The findings demonstrated that high adherence to the injectable leads to meaningfully lower healthcare utilization and costs for patients with Opioid Use Disorder (OUD). |
| 14 July 2025 | Hikma Pharmaceuticals PLC | The company launched Morphine Sulfate Injection, USP, in prefilled syringes featuring 2mg/mL and 4mg/mL dosages in the United States. | This launch strengthens the company’s position as a top-three supplier of generic injectable medicines, addressing a market with annual sales of approximately $75 million. |
| 07 April 2025 | Viatris Inc. | The pharmaceutical giant agreed to a $335 million settlement to resolve long-standing opioid-related claims brought by state and local governments. | The agreement provides legal closure for the company through annual payments over nine years, funding government efforts to mitigate the opioid crisis. |
| 28 March 2025 | Scienture Holdings, Inc. | The subsidiary Scienture, LLC signed an exclusive licensing agreement with Summit Biosciences Inc. for the U.S. commercialization of REZENOPY. | This 10mg naloxone nasal spray serves as a high-dose emergency intervention to counteract potential or confirmed opioid overdoses. |
| 30 January 2025 | Viatris Inc. (Vertex Pharmaceuticals) | The U.S. FDA granted approval for Journavx (suzetrigine), a novel non-opioid medication designed to treat moderate to severe acute pain. | As a highly anticipated opioid alternative, this drug aims to capture market share from traditional opioids by providing effective analgesia without the risk of addiction. |
| 08 January 2025 | Hikma Pharmaceuticals PLC | The company entered into an exclusive commercial partnership with Emergent BioSolutions for the distribution of KLOXXADO (naloxone HCl nasal spray 8 mg). | The partnership expands the availability of high-concentration naloxone in the U.S. and Canada to combat increasingly potent synthetic opioid overdoses. |
Opioids Drugs Market Scope: Inquire before buying
| Global Opioids Drugs Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2032 |
| Historical Data: | 2018 to 2022 | Market Size in 2025: | 31.17 USD Billion |
| Forecast Period 2026-2032 CAGR: | 4.54% | Market Size in 2032: | 42.53 USD Billion |
| Segments Covered: | by Product Type | Immediate-Release (IR) Extended-Release (ER) |
|
| by Distribution Channel | Retail Pharmacies Hospital Pharmacies Online Pharmacies |
||
| by Route of Administration | Oral Injectable Transdermal |
||
| by End User | Hospitals Specialty Clinics Homecare Settings Ambulatory Surgical Centers Long-term Care Facilities Research & Academic Institutes |
||
Opioids Drugs Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Opioids Drugs Market, Key Players are:
Apotex Inc.
Pfizer Inc.
Johnson & Johnson
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Mallinckrodt Pharmaceuticals
Endo International plc
AbbVie Inc.
Novartis AG
Sanofi S.A.
Bayer AG
GlaxoSmithKline plc
Merck & Co., Inc.
Hikma Pharmaceuticals plc
Mylan N.V. (Viatris Inc.)
Sun Pharmaceutical Industries Ltd.
Dr. Reddy’s Laboratories Ltd.
Cipla Inc.
Aurobindo Pharma Ltd.
Lupin Limited
Zydus Lifesciences Ltd.
Fresenius Kabi AG
Amneal Pharmaceuticals Inc.
Collegium Pharmaceutical Inc.
Trevena Inc.
Assertio Holdings Inc.
Table of Contents
1. Global Opioids Drugs Market Introduction
1.1. Study Assumption and Market Definition
1.2. Scope of the Study
1.3. Executive Summary
2. Global Opioids Drugs Market: Competitive Landscape
2.1. MMR Competition Matrix
2.2. Competitive Landscape
2.3. Key Players Benchmarking
2.3.1. Company Name
2.3.2. Business Segment
2.3.3. End-user Segment
2.3.4. Revenue (2025)
2.3.5. Company Locations
2.4. Leading Global Opioids Drugs Market Companies, by market capitalization
2.5. Market Structure
2.5.1. Market Leaders
2.5.2. Market Followers
2.5.3. Emerging Players
2.6. Mergers and Acquisitions Details
3. Global Opioids Drugs Market: Dynamics
3.1. Global Opioids Drugs Market Trends by Region
3.1.1. North America Global Opioids Drugs Market Trends
3.1.2. Europe Global Opioids Drugs Market Trends
3.1.3. Asia Pacific Global Opioids Drugs Market Trends
3.1.4. Middle East and Africa Global Opioids Drugs Market Trends
3.1.5. South America Global Opioids Drugs Market Trends
3.2. Global Opioids Drugs Market Dynamics by Region
3.2.1. North America
3.2.1.1. North America Global Opioids Drugs Market Drivers
3.2.1.2. North America Global Opioids Drugs Market Restraints
3.2.1.3. North America Global Opioids Drugs Market Opportunities
3.2.1.4. North America Global Opioids Drugs Market Challenges
3.2.2. Europe
3.2.2.1. Europe Global Opioids Drugs Market Drivers
3.2.2.2. Europe Global Opioids Drugs Market Restraints
3.2.2.3. Europe Global Opioids Drugs Market Opportunities
3.2.2.4. Europe Global Opioids Drugs Market Challenges
3.2.3. Asia Pacific
3.2.3.1. Asia Pacific Global Opioids Drugs Market Drivers
3.2.3.2. Asia Pacific Global Opioids Drugs Market Restraints
3.2.3.3. Asia Pacific Global Opioids Drugs Market Opportunities
3.2.3.4. Asia Pacific Global Opioids Drugs Market Challenges
3.2.4. Middle East and Africa
3.2.4.1. Middle East and Africa Global Opioids Drugs Market Drivers
3.2.4.2. Middle East and Africa Global Opioids Drugs Market Restraints
3.2.4.3. Middle East and Africa Global Opioids Drugs Market Opportunities
3.2.4.4. Middle East and Africa Global Opioids Drugs Market Challenges
3.2.5. South America
3.2.5.1. South America Global Opioids Drugs Market Drivers
3.2.5.2. South America Global Opioids Drugs Market Restraints
3.2.5.3. South America Global Opioids Drugs Market Opportunities
3.2.5.4. South America Global Opioids Drugs Market Challenges
3.3. PORTER's Five Forces Analysis
3.4. PESTLE Analysis
3.5. Technology Roadmap
3.6. Regulatory Landscape by Region
3.6.1. North America
3.6.2. Europe
3.6.3. Asia Pacific
3.6.4. Middle East and Africa
3.6.5. South America
3.7. Key Opinion Leader Analysis For Global Opioids Drugs Industry
3.8. Analysis of Government Schemes and Initiatives For Global Opioids Drugs Industry
3.9. Global Opioids Drugs Market Trade Analysis
3.10. The Global Pandemic Impact on Global Opioids Drugs Market
4. Global Opioids Drugs Market: Global Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
4.1. Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
4.1.1. Immediate-Release (IR)
4.1.2. Extended-Release (ER)
4.2. Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
4.2.1. Retail Pharmacies
4.2.2. Hospital Pharmacies
4.2.3. Online Pharmacies
4.3. Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
4.3.1. Oral
4.3.2. Injectable
4.3.3. Transdermal
4.4. Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
4.4.1. Hospitals
4.4.2. Specialty Clinics
4.4.3. Homecare Settings
4.4.4. Ambulatory Surgical Centers
4.4.5. Long-term Care Facilities
4.4.6. Research & Academic Institutes
4.5. Global Opioids Drugs Market Size and Forecast, by Region (2025-2032)
4.5.1. North America
4.5.2. Europe
4.5.3. Asia Pacific
4.5.4. Middle East and Africa
4.5.5. South America
5. North America Global Opioids Drugs Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
5.1. North America Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
5.1.1. Immediate-Release (IR)
5.1.2. Extended-Release (ER)
5.2. North America Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
5.2.1. Retail Pharmacies
5.2.2. Hospital Pharmacies
5.2.3. Online Pharmacies
5.3. North America Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
5.3.1. Oral
5.3.2. Injectable
5.3.3. Transdermal
5.4. North America Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
5.4.1. Hospitals
5.4.2. Specialty Clinics
5.4.3. Homecare Settings
5.4.4. Ambulatory Surgical Centers
5.4.5. Long-term Care Facilities
5.4.6. Research & Academic Institutes
5.5. North America Global Opioids Drugs Market Size and Forecast, by Country (2025-2032)
5.5.1. United States
5.5.1.1. United States Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
5.5.1.1.1. Immediate-Release (IR)
5.5.1.1.2. Extended-Release (ER)
5.5.1.2. United States Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
5.5.1.2.1. Retail Pharmacies
5.5.1.2.2. Hospital Pharmacies
5.5.1.2.3. Online Pharmacies
5.5.1.3. United States Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
5.5.1.3.1. Oral
5.5.1.3.2. Injectable
5.5.1.3.3. Transdermal
5.5.1.4. United States Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
5.5.1.4.1. Hospitals
5.5.1.4.2. Specialty Clinics
5.5.1.4.3. Homecare Settings
5.5.1.4.4. Ambulatory Surgical Centers
5.5.1.4.5. Long-term Care Facilities
5.5.1.4.6. Research & Academic Institutes
5.5.2. Canada
5.5.2.1. Canada Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
5.5.2.1.1. Immediate-Release (IR)
5.5.2.1.2. Extended-Release (ER)
5.5.2.2. Canada Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
5.5.2.2.1. Retail Pharmacies
5.5.2.2.2. Hospital Pharmacies
5.5.2.2.3. Online Pharmacies
5.5.2.3. Canada Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
5.5.2.3.1. Oral
5.5.2.3.2. Injectable
5.5.2.3.3. Transdermal
5.5.2.4. Canada Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
5.5.2.4.1. Hospitals
5.5.2.4.2. Specialty Clinics
5.5.2.4.3. Homecare Settings
5.5.2.4.4. Ambulatory Surgical Centers
5.5.2.4.5. Long-term Care Facilities
5.5.2.4.6. Research & Academic Institutes
5.5.3. Mexico
5.5.3.1. Mexico Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
5.5.3.1.1. Immediate-Release (IR)
5.5.3.1.2. Extended-Release (ER)
5.5.3.2. Mexico Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
5.5.3.2.1. Retail Pharmacies
5.5.3.2.2. Hospital Pharmacies
5.5.3.2.3. Online Pharmacies
5.5.3.3. Mexico Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
5.5.3.3.1. Oral
5.5.3.3.2. Injectable
5.5.3.3.3. Transdermal
5.5.3.4. Mexico Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
5.5.3.4.1. Hospitals
5.5.3.4.2. Specialty Clinics
5.5.3.4.3. Homecare Settings
5.5.3.4.4. Ambulatory Surgical Centers
5.5.3.4.5. Long-term Care Facilities
5.5.3.4.6. Research & Academic Institutes
6. Europe Global Opioids Drugs Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
6.1. Europe Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.2. Europe Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.3. Europe Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.4. Europe Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5. Europe Global Opioids Drugs Market Size and Forecast, by Country (2025-2032)
6.5.1. United Kingdom
6.5.1.1. United Kingdom Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.1.2. United Kingdom Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.1.3. United Kingdom Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.1.4. United Kingdom Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.2. France
6.5.2.1. France Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.2.2. France Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.2.3. France Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.2.4. France Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.3. Germany
6.5.3.1. Germany Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.3.2. Germany Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.3.3. Germany Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.3.4. Germany Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.4. Italy
6.5.4.1. Italy Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.4.2. Italy Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.4.3. Italy Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.4.4. Italy Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.5. Spain
6.5.5.1. Spain Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.5.2. Spain Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.5.3. Spain Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.5.4. Spain Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.6. Sweden
6.5.6.1. Sweden Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.6.2. Sweden Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.6.3. Sweden Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.6.4. Sweden Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.7. Austria
6.5.7.1. Austria Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.7.2. Austria Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.7.3. Austria Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.7.4. Austria Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
6.5.8. Rest of Europe
6.5.8.1. Rest of Europe Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
6.5.8.2. Rest of Europe Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
6.5.8.3. Rest of Europe Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
6.5.8.4. Rest of Europe Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7. Asia Pacific Global Opioids Drugs Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
7.1. Asia Pacific Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.2. Asia Pacific Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.3. Asia Pacific Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.4. Asia Pacific Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5. Asia Pacific Global Opioids Drugs Market Size and Forecast, by Country (2025-2032)
7.5.1. China
7.5.1.1. China Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.1.2. China Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.1.3. China Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.1.4. China Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.2. S Korea
7.5.2.1. S Korea Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.2.2. S Korea Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.2.3. S Korea Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.2.4. S Korea Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.3. Japan
7.5.3.1. Japan Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.3.2. Japan Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.3.3. Japan Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.3.4. Japan Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.4. India
7.5.4.1. India Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.4.2. India Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.4.3. India Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.4.4. India Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.5. Australia
7.5.5.1. Australia Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.5.2. Australia Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.5.3. Australia Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.5.4. Australia Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.6. Indonesia
7.5.6.1. Indonesia Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.6.2. Indonesia Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.6.3. Indonesia Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.6.4. Indonesia Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.7. Malaysia
7.5.7.1. Malaysia Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.7.2. Malaysia Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.7.3. Malaysia Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.7.4. Malaysia Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.8. Vietnam
7.5.8.1. Vietnam Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.8.2. Vietnam Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.8.3. Vietnam Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.8.4. Vietnam Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.9. Taiwan
7.5.9.1. Taiwan Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.9.2. Taiwan Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.9.3. Taiwan Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.9.4. Taiwan Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
7.5.10. Rest of Asia Pacific
7.5.10.1. Rest of Asia Pacific Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
7.5.10.2. Rest of Asia Pacific Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
7.5.10.3. Rest of Asia Pacific Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
7.5.10.4. Rest of Asia Pacific Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
8. Middle East and Africa Global Opioids Drugs Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
8.1. Middle East and Africa Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
8.2. Middle East and Africa Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
8.3. Middle East and Africa Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
8.4. Middle East and Africa Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
8.5. Middle East and Africa Global Opioids Drugs Market Size and Forecast, by Country (2025-2032)
8.5.1. South Africa
8.5.1.1. South Africa Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
8.5.1.2. South Africa Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
8.5.1.3. South Africa Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
8.5.1.4. South Africa Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
8.5.2. GCC
8.5.2.1. GCC Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
8.5.2.2. GCC Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
8.5.2.3. GCC Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
8.5.2.4. GCC Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
8.5.3. Nigeria
8.5.3.1. Nigeria Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
8.5.3.2. Nigeria Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
8.5.3.3. Nigeria Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
8.5.3.4. Nigeria Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
8.5.4. Rest of ME&A
8.5.4.1. Rest of ME&A Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
8.5.4.2. Rest of ME&A Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
8.5.4.3. Rest of ME&A Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
8.5.4.4. Rest of ME&A Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
9. South America Global Opioids Drugs Market Size and Forecast by Segmentation (in USD Billion) 2025-2032
9.1. South America Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
9.2. South America Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
9.3. South America Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
9.4. South America Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
9.5. South America Global Opioids Drugs Market Size and Forecast, by Country (2025-2032)
9.5.1. Brazil
9.5.1.1. Brazil Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
9.5.1.2. Brazil Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
9.5.1.3. Brazil Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
9.5.1.4. Brazil Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
9.5.2. Argentina
9.5.2.1. Argentina Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
9.5.2.2. Argentina Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
9.5.2.3. Argentina Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
9.5.2.4. Argentina Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
9.5.3. Rest Of South America
9.5.3.1. Rest Of South America Global Opioids Drugs Market Size and Forecast, by Product Type (2025-2032)
9.5.3.2. Rest Of South America Global Opioids Drugs Market Size and Forecast, by Distribution Channel (2025-2032)
9.5.3.3. Rest Of South America Global Opioids Drugs Market Size and Forecast, by Route of Administration (2025-2032)
9.5.3.4. Rest Of South America Global Opioids Drugs Market Size and Forecast, by End User (2025-2032)
10. Company Profile: Key Players
10.1. Apotex Inc.
10.1.1. Company Overview
10.1.2. Business Portfolio
10.1.3. Financial Overview
10.1.4. SWOT Analysis
10.1.5. Strategic Analysis
10.1.6. Scale of Operation (small, medium, and large)
10.1.7. Details on Partnership
10.1.8. Regulatory Accreditations and Certifications Received by Them
10.1.9. Awards Received by the Firm
10.1.10. Recent Developments
10.2. Pfizer Inc.
10.3. Johnson & Johnson
10.4. Purdue Pharma L.P.
10.5. Teva Pharmaceutical Industries Ltd.
10.6. Mallinckrodt Pharmaceuticals
10.7. Endo International plc
10.8. AbbVie Inc.
10.9. Novartis AG
10.10. Sanofi S.A.
10.11. Bayer AG
10.12. GlaxoSmithKline plc
10.13. Merck & Co.
10.14. Inc.
10.15. Hikma Pharmaceuticals plc
10.16. Mylan N.V. (Viatris Inc.)
10.17. Sun Pharmaceutical Industries Ltd.
10.18. Dr. Reddy’s Laboratories Ltd.
10.19. Cipla Inc.
10.20. Aurobindo Pharma Ltd.
10.21. Lupin Limited
10.22. Zydus Lifesciences Ltd.
10.23. Fresenius Kabi AG
10.24. Amneal Pharmaceuticals Inc.
10.25. Collegium Pharmaceutical Inc.
10.26. Trevena Inc.
10.27. Assertio Holdings Inc.
11. Key Findings
12. Industry Recommendations
13. Global Opioids Drugs Market: Research Methodology
14. Terms and Glossary